717 related articles for article (PubMed ID: 20146695)
1. Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis.
Mammen AL
Ann N Y Acad Sci; 2010 Jan; 1184():134-53. PubMed ID: 20146695
[TBL] [Abstract][Full Text] [Related]
2. Polymyositis, dermatomyositis, and autoimmune necrotizing myopathy: clinical features.
Khan S; Christopher-Stine L
Rheum Dis Clin North Am; 2011 May; 37(2):143-58, v. PubMed ID: 21444016
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies in adult patients with idiopathic inflammatory myopathies in Buenos Aires.
Gómez GN; Gargiulo Mde L; Pérez N; Collado MV; Suárez LV; Khoury M; Sarano JF
Medicina (B Aires); 2016; 76(3):129-34. PubMed ID: 27295700
[TBL] [Abstract][Full Text] [Related]
4. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy.
Kao AH; Lacomis D; Lucas M; Fertig N; Oddis CV
Arthritis Rheum; 2004 Jan; 50(1):209-15. PubMed ID: 14730618
[TBL] [Abstract][Full Text] [Related]
5. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].
Eymard B
Presse Med; 2003 Oct; 32(35):1656-67. PubMed ID: 14631270
[TBL] [Abstract][Full Text] [Related]
6. The role of MRI in the assessment of polymyositis and dermatomyositis.
Tomasová Studynková J; Charvát F; Jarosová K; Vencovsky J
Rheumatology (Oxford); 2007 Jul; 46(7):1174-9. PubMed ID: 17500079
[TBL] [Abstract][Full Text] [Related]
7. The geoepidemiology of autoimmune muscle disease.
Prieto S; Grau JM
Autoimmun Rev; 2010 Mar; 9(5):A330-4. PubMed ID: 19906360
[TBL] [Abstract][Full Text] [Related]
8. Immune manifestations of inflammatory muscle disease.
Targoff IN
Rheum Dis Clin North Am; 1994 Nov; 20(4):857-80. PubMed ID: 7855326
[TBL] [Abstract][Full Text] [Related]
9. [Myositis-specific autoantibodies and their clinical significance].
Suzuki S
Brain Nerve; 2011 Nov; 63(11):1197-203. PubMed ID: 22068472
[TBL] [Abstract][Full Text] [Related]
10. Update on idiopathic inflammatory myopathies.
Briani C; Doria A; Sarzi-Puttini P; Dalakas MC
Autoimmunity; 2006 May; 39(3):161-70. PubMed ID: 16769649
[TBL] [Abstract][Full Text] [Related]
11. [Dermatomyositis and polymyositis].
Pellissier JF; Civatte M; Fernandez C; Bartoli C; Chetaille B; Schleinitz N; Figarella-Branger D
Rev Neurol (Paris); 2002 Oct; 158(10 Pt 1):934-47. PubMed ID: 12407302
[TBL] [Abstract][Full Text] [Related]
12. Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups.
Sarkar K; Weinberg CR; Oddis CV; Medsger TA; Plotz PH; Reveille JD; Arnett FC; Targoff IN; Genth E; Love LA; Miller FW
Arthritis Rheum; 2005 Aug; 52(8):2433-8. PubMed ID: 16052581
[TBL] [Abstract][Full Text] [Related]
13. Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy.
Venalis P; Lundberg IE
Rheumatology (Oxford); 2014 Mar; 53(3):397-405. PubMed ID: 23970542
[TBL] [Abstract][Full Text] [Related]
14. The Prevalence of Individual Histopathologic Features Varies according to Autoantibody Status in Muscle Biopsies from Patients with Dermatomyositis.
Pinal-Fernandez I; Casciola-Rosen LA; Christopher-Stine L; Corse AM; Mammen AL
J Rheumatol; 2015 Aug; 42(8):1448-54. PubMed ID: 26443871
[TBL] [Abstract][Full Text] [Related]
15. [Laboratory diagnostics of polymyositis/dermatomyositis].
Prus V; Bedeković D
Reumatizam; 2012; 59(2):27-30. PubMed ID: 23745451
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory myopathies: evaluation and management.
Greenberg SA
Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525
[TBL] [Abstract][Full Text] [Related]
17. The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies.
Li S; Ge Y; Yang H; Wang T; Zheng X; Peng Q; Lu X; Wang G
Clin Rheumatol; 2019 Aug; 38(8):2171-2179. PubMed ID: 30863950
[TBL] [Abstract][Full Text] [Related]
18. [Clinical and pathological investigation of polymyositis and dermatomyositis: report of 83 cases].
Li Q; Lu BX; Zhou L; An SL
Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1139-40. PubMed ID: 12480599
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic aspects of dermatomyositis, polymyositis and overlap myositis.
Gherardi RK
Presse Med; 2011 Apr; 40(4 Pt 2):e209-18. PubMed ID: 21376512
[TBL] [Abstract][Full Text] [Related]
20. Dermatomyositis and polymyositis: new treatment targets on the horizon.
Hak AE; de Paepe B; de Bleecker JL; Tak PP; de Visser M
Neth J Med; 2011 Oct; 69(10):410-21. PubMed ID: 22058260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
